The maternal microbiome in childhood growth and immunity during undernutrition
营养不良期间儿童生长和免疫中的母体微生物组
基本信息
- 批准号:10452697
- 负责人:
- 金额:$ 34.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-16 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:16S ribosomal RNA sequencingAddressAdoptive TransferAdultAgeAnimalsB-LymphocytesBehavior ControlBirthBone GrowthBreedingCell physiologyCellsCessation of lifeCharacteristicsChemicalsChildChild HealthChildbirthChildhoodCognitiveCognitive deficitsCommunicable DiseasesCommunitiesComplicationDataDefectDevelopmentEnvironmentFlow CytometryFosteringGene Expression ProfilingGerm-FreeGnotobioticGoalsGrowthHealthHeterozygoteHomozygoteHousingHumanImmuneImmune responseImmune systemImmunityImmunotherapeutic agentInfant HealthInfrastructureInterventionInvestigationLeadLifeLymphoidLymphopoiesisMalnutritionMaternal HealthMediatingMetabolicMetabolic DiseasesMicrobeModelingMothersMusNeonatalPartner in relationshipPathway interactionsPhenotypePhysiologicalPlayPregnancyProbioticsProductivityRag1 MouseResearchRiskRoleSamplingShapesSignal PathwaySignal TransductionSorting - Cell MovementSyndromeSystems BiologyT cell responseT cell therapyT-LymphocyteTechniquesTestingTherapeutic InterventionTimeUniversitiesVirginiaVulnerable PopulationsWeightWorkadaptive immunitybonechemokinecognitive functiondisorder riskexperienceexperimental studyfetalglobal healthgut microbesgut microbiomegut microbiotaimmune activationimmune functionimprovedinnovationinsightintergenerationalmachine learning algorithmmaternal microbiomematernal microbiotamembermicrobialmicrobial communitymicrobiomemicrobiotamouse modelnovel strategiesoffspringpostnatalpostnatal periodprenatalprogenitorpuprandom foresttargeted treatmenttherapeutic targettomographytransmission process
项目摘要
Globally, undernutrition contributes to 44% of childhood deaths under the age of five 1. Stunting, or reduced linear growth, is a major complication of undernutrition that is associated with increased risk of metabolic and infectious disease, reduced educational attainment and poor cognitive function later in life 3. Stunted mothers are more likely to experience complications during childbirth, and to give birth to stunted children 5. In turn, many children that are born stunted do not recover despite current therapeutic interventions 4. Therefore, stunting is often referred to as an intergenerational syndrome, and new approaches are desperately needed to improve childhood growth in vulnerable populations. The maternal immune system plays a major role in shaping offspring physical, cognitive and immune development. The gut microbiota likewise influences both local and systemic immunity, raising the possibility that the maternal microbiome could influence fetal and childhood development. We hypothesize that maternal gut microbial composition shapes the fetal immune environment to control offspring growth and immune development during undernutrition. We propose to use a mouse model of intergenerational undernutrition to identify specific immune and microbial targets for therapeutic intervention. Our preliminary data demonstrate that breeding mice colonized with microbiota from healthy or severely stunted donors produce offspring with divergent weight, bone, and immune developmental phenotypes that persist into maturity. We will use this model to isolate the role of the maternal gut microbiome from the neonatal microbiome, giving critical insight into the window of potential intervention. We will also identify specific subsets of microbes that are capable of influencing offspring growth and immune development and characterize microbial metabolic products associated with these changes. Finally, we will identify maternal immune cells and signaling pathways that respond to these microbial communities to control healthy growth and immune development in offspring. These experiments will identify specific microbial species as well as host immune pathways to target therapeutically and define the appropriate developmental stage in which to intervene. The Cowardin lab is located within the Child Health Research Center at the University of Virginia, and as a member of the Trans- University Miocrobiome Initiative, is uniquely suited to pursuing these studies. The lab has both the infrastructure and expertise required for successful completion of these goals. Ultimately, this proposal will lead to potential probiotic and immunotherapeutic treatments to disrupt the transmission of stunting from mother to child.
在全球范围内,营养不良导致 44% 的 5 岁以下儿童死亡1。发育迟缓或线性生长减慢是营养不良的一个主要并发症,与代谢和传染病风险增加、受教育程度降低以及日后认知功能差有关3. 发育迟缓的母亲更有可能在分娩过程中出现并发症,并生出发育迟缓的儿童 5. 反过来,尽管目前采取了治疗干预措施,但许多出生时发育迟缓的儿童仍无法康复4. 因此,发育迟缓通常被称为代际综合症,迫切需要新的方法来改善弱势群体的儿童生长。母体免疫系统在塑造后代身体、认知和免疫发育方面发挥着重要作用。肠道微生物群同样影响局部和全身免疫,增加了母体微生物群影响胎儿和儿童发育的可能性。我们假设母体肠道微生物组成塑造胎儿免疫环境,以控制营养不良期间后代的生长和免疫发育。我们建议使用代际营养不良的小鼠模型来确定治疗干预的特定免疫和微生物靶标。我们的初步数据表明,被来自健康或严重发育不良供体的微生物群定殖的繁殖小鼠产生的后代具有不同的体重、骨骼和免疫发育表型,并且这些后代持续到成熟。我们将使用该模型将母体肠道微生物组与新生儿微生物组的作用分开,从而对潜在干预窗口提供重要的见解。我们还将确定能够影响后代生长和免疫发育的特定微生物子集,并表征与这些变化相关的微生物代谢产物。最后,我们将确定对这些微生物群落做出反应的母体免疫细胞和信号通路,以控制后代的健康生长和免疫发育。这些实验将识别特定的微生物种类以及宿主免疫途径以进行治疗,并确定进行干预的适当发育阶段。 Cowardin 实验室位于弗吉尼亚大学儿童健康研究中心内,作为跨大学微生物组计划的成员,非常适合开展这些研究。该实验室拥有成功完成这些目标所需的基础设施和专业知识。最终,该提案将带来潜在的益生菌和免疫治疗方法,以阻止发育迟缓从母亲到孩子的传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carrie Adeline Cowardin其他文献
Carrie Adeline Cowardin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carrie Adeline Cowardin', 18)}}的其他基金
The maternal microbiome in childhood growth and immunity during undernutrition
营养不良期间儿童生长和免疫中的母体微生物组
- 批准号:
10276044 - 财政年份:2021
- 资助金额:
$ 34.83万 - 项目类别:
The maternal microbiome in childhood growth and immunity during undernutrition
营养不良期间儿童生长和免疫中的母体微生物组
- 批准号:
10626121 - 财政年份:2021
- 资助金额:
$ 34.83万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer
改造 T 细胞以克服抑制性受体信号,这些信号限制了过继性细胞疗法对卵巢癌的疗效
- 批准号:
10526155 - 财政年份:2023
- 资助金额:
$ 34.83万 - 项目类别:
Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcoma
调节PD-1/PD-L1检查点促进肉瘤患者HER2 CAR T细胞的抗肿瘤活性
- 批准号:
10562836 - 财政年份:2023
- 资助金额:
$ 34.83万 - 项目类别:
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease
关节内药物递送调节炎症性关节疾病中的免疫细胞
- 批准号:
10856753 - 财政年份:2023
- 资助金额:
$ 34.83万 - 项目类别:
Development of Gamma delta CAR-T cells to target CNS HIV reservoir
开发针对 CNS HIV 储存库的 Gamma delta CAR-T 细胞
- 批准号:
10620021 - 财政年份:2023
- 资助金额:
$ 34.83万 - 项目类别:
Spatial genomic tools to interrogate T cell clonotypes, tumor clones and the microenvironment
用于询问 T 细胞克隆型、肿瘤克隆和微环境的空间基因组工具
- 批准号:
10565141 - 财政年份:2023
- 资助金额:
$ 34.83万 - 项目类别: